Member Info for squadraazzura

Excellent news for any private company wanting to monitor the infection rate of its employees. Innovation and breaking new grounds is the tradition with Nova. The sky is the limit.

The question I always asked is how can we develop a vaccine in just one year. For Covid, phase 3 is using the whole humanity as guinea pigs. So I won't take the jab because I don't want to be part of the experiment.

https://brighteon.com/e86a8f0d-bae2-4c3c-926d-61c60c6e4c38

Here you are Wilson:
Check out Viela financials in item 6 in table of contents. AZN got $775 million for 26.7%. This puts a price tag on Viela at $2.9 billion for a company that makes 11.6 million in sales and a net loss of $150.6 million. Follow your logic and put a price tag on NCYT now.
hTTps://ir.vielabio.com/static-files/88b2da24-1680-49a6-b69b-5f8c14393fbb

This is the $2.9 billion company - Take a look at item 6. - - - hTTps://ir.vielabio.com/static-files/88b2da24-1680-49a6-b69b-5f8c14393fbb

Check out Viela financials in item 6 in table of contents. AZN got $775 million for 26.7%. This puts a price tag on Viela at $2.9 billion for a company that makes 11.6 million in sales and a net loss of $150.6 million. Follow your logic and put a price tag on NCYT now.
hTTps://www.astrazeneca.com/media-centre/press-releases/2021/divestment-of-viela-shareholding-completed.html

300 PCR tests for a minimum value of £150 million.
700 additional PCR tests would fetch £350 million.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
This first phase of the contract will involve the immediate deployment of 300 PCR instruments,related kits and support services with a minimum value of £150millionfor the first 14 weeks. Based on this initial period, a further £100 million of revenue could be expected for the subsequent 10 weeks,however volumes can be varied up or down subject to certain notice criteria given by the DHSC.
The second phase of the contract, which is optional by the DHSC, allows for the provision of up to 700 additional PCR instruments, related kits and support services, as well as additional COVID-19 products from the Company’s portfolio where required. Depending upon the uptake,phase two of the contract could generate considerably more sales than the first phase. The intended use of the contract is for Novacyt to support the urgent requirement for COVID-19testing of patients in the NHS. In addition to the provision of products, the Company will also provide training and maintenance services for the q16 and q32 instrument platforms.Novacyt has the capacity to meet the demand of both phases of this new contract,as well as to continue to build its sales across international markets.

This tells everything one needs to know: "As a result of significant work, focus and innovation, the scale and financial performance of the business continued to accelerate during the second half of the year. This was driven by the continued successful global commercialisation of the Company's COVID-19 product portfolio, underpinned by one of the world's first approved polymerase chain reaction (PCR) tests for the virus, and has resulted in the rapid transformation of Novacyt into a leading European integrated molecular diagnostic player." "As detailed at the time of the acquisition, the Company is focused on delivering higher manufacturing volumes at IT-IS to reduce its cost of goods and therefore improve the gross margin of its instrument sales."

This has HALF the revenues of NCYT ...

SANOFI rings the bell ...

Https://www.google.co.uk/amp/s/www.livemint.com/companies/news/roche-to-buy-us-firm-genmark-diagnostics-for-1-8-bn/amp-11615796285837.html

Open Letter to the WHO: Immediately Halt All Covid-19 Mass Vaccinations-Geert Vanden Bossche, DMV, PhD
HTTps://fos-sa.org/2021/03/12/open-letter-to-the-who-immediately-halt-all-covid-19-mass-vaccinations-geert-vanden-bossche-dmv-phd/

Regarding Yourgene, it has signed a manufacturing deal with Novacyt on 25 March 2020. It is listed in Nova RNS.

Like vultures, they push PI's slowly but surely to sell out of boredom and impatience. This is what they want psychologically to achieve: You give up and sell. They will win twice: 1/ They will collect the profits from their shorts and 2/ They will get in cheaper for the recovery. So the best response is to keep calm and let them play their games. One morning they will leave one arm and one leg via a bomb shell in the form of a heavy RNS. It's now long due. It's a while since we haven't heard anything.

Like vultures, the push PI's slowly but surely to sell our of boredom. This is what they want psychologically to achieve: You give up and sell. They will win twice: 1/ They will collect the profits from their shorts and 2/ They will get in cheaper for the recovery. So the best response is to keep calm and et them play their games. Then one morning they will leave one arm and one leg via a bomb shell in the form of heavy RNS. It's now long due. It's a while since we haven't heard anything ...

French hospitals to transfer Covid-19 patients as critical cases reach three-month high
https://www.france24.com/en/europe/20210311-french-hospitals-to-transfer-covid-19-patients-as-critical-cases-reach-three-month-high

ShaunP - Thanks for the Nova useful contract summary.

Https://www.yourlocalguardian.co.uk/news/19151109.south-africa-covid-variant-confirmed-two-wandsworth-wards/

Https://www.pharmaceutical-technology.com/special-focus/covid-19/international-update-global-covid-infections-pass-118-million-variant-strains-becoming-dominant-in-us/

One has to look at what's happening in Europe (France, Italy etc.) and South America (Brazil) and the US where it is spreading at a huge rate. There are 7.7 billion people on the planet. Testing will never go away.
hTTps://www.worldometers.info/coronavirus/#countries